Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

bioAffinity Technologies (BIAF) Net Income towards Common Stockholders: 2022-2025

Historic Net Income towards Common Stockholders for bioAffinity Technologies (BIAF) over the last 4 years, with Sep 2025 value amounting to -$5.1 million.

  • bioAffinity Technologies' Net Income towards Common Stockholders fell 152.45% to -$5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.7 million, marking a year-over-year decrease of 74.51%. This contributed to the annual value of -$9.0 million for FY2024, which is 13.89% down from last year.
  • Latest data reveals that bioAffinity Technologies reported Net Income towards Common Stockholders of -$5.1 million as of Q3 2025, which was down 24.39% from -$4.1 million recorded in Q2 2025.
  • bioAffinity Technologies' Net Income towards Common Stockholders' 5-year high stood at -$88,052 during Q2 2022, with a 5-year trough of -$5.1 million in Q3 2025.
  • Its 3-year average for Net Income towards Common Stockholders is -$2.6 million, with a median of -$2.3 million in 2023.
  • Data for bioAffinity Technologies' Net Income towards Common Stockholders shows a peak YoY increase of 53.43% (in 2023) and a maximum YoY decrease of 1,876.30% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows bioAffinity Technologies' Net Income towards Common Stockholders stood at -$1.7 million in 2022, then slumped by 41.72% to -$2.4 million in 2023, then declined by 25.02% to -$3.0 million in 2024, then crashed by 152.45% to -$5.1 million in 2025.
  • Its last three reported values are -$5.1 million in Q3 2025, -$4.1 million for Q2 2025, and -$2.7 million during Q1 2025.